KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Zimmer Biomet Holdings (ZBH) EBT Margin (2016 - 2026)

Zimmer Biomet Holdings has reported EBT Margin over the past 18 years, most recently at 14.44% for Q1 2026.

  • For Q1 2026, EBT Margin rose 244.0% year-over-year to 14.44%; the TTM value through Mar 2026 reached 12.26%, up 188.0%, while the annual FY2025 figure was 11.64%, 142.0% up from the prior year.
  • EBT Margin for Q1 2026 was 14.44% at Zimmer Biomet Holdings, up from 10.05% in the prior quarter.
  • Over five years, EBT Margin peaked at 15.66% in Q1 2023 and troughed at 1.84% in Q4 2024.
  • A 5-year average of 11.61% and a median of 12.0% in 2025 define the central range for EBT Margin.
  • Biggest five-year swings in EBT Margin: skyrocketed 958bps in 2023 and later crashed -1283bps in 2024.
  • Year by year, EBT Margin stood at 9.18% in 2022, then soared by 60bps to 14.66% in 2023, then tumbled by -87bps to 1.84% in 2024, then surged by 447bps to 10.05% in 2025, then surged by 44bps to 14.44% in 2026.
  • Business Quant data shows EBT Margin for ZBH at 14.44% in Q1 2026, 10.05% in Q4 2025, and 13.95% in Q3 2025.